Cargando…
How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease
The retest effect—improvement of performance on second exposure to a task—may impede the detection of cognitive decline in clinical trials for neurodegenerative diseases. We assessed the impact of the retest effect in Huntington’s disease trials, and investigated its possible neutralization. We enro...
Autores principales: | Schramm, Catherine, Katsahian, Sandrine, Youssov, Katia, Démonet, Jean-François, Krystkowiak, Pierre, Supiot, Frédéric, Verny, Christophe, Cleret de Langavant, Laurent, Bachoud-Lévi, Anne-Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703129/ https://www.ncbi.nlm.nih.gov/pubmed/26714284 http://dx.doi.org/10.1371/journal.pone.0145842 |
Ejemplares similares
-
Longitudinal Study of Informed Consent in Innovative Therapy Research: Experience and Provisional Recommendations from a Multicenter Trial of Intracerebral Grafting
por: Cleret de Langavant, Laurent, et al.
Publicado: (2015) -
Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington’s Disease
por: Lemercier, Pablo, et al.
Publicado: (2022) -
Effectiveness of Anti-Psychotics and Related Drugs in the Huntington French-Speaking Group Cohort
por: Désaméricq, Gaëlle, et al.
Publicado: (2014) -
Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington’s Disease
por: Salem, Linda, et al.
Publicado: (2016) -
COMT Val(158)Met Polymorphism Modulates Huntington's Disease Progression
por: de Diego-Balaguer, Ruth, et al.
Publicado: (2016)